CHAMPIONS ONCOLOGY INC CSBR
COM NEW · Common Stock · CUSIP 15870P307
American technology company
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBaltimore, MD
- Founded2001
- Websitechampionsoncology.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 13.6m as of 2024-07-18, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $5.17. Options: 2 managers hold calls ($17.1k notional), 3 hold puts ($62.5k).
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 32 |
| Q4 2022 | 30 |
| Q1 2023 | 31 |
| Q2 2023 | 29 |
| Q3 2023 | 30 |
| Q4 2023 | 24 |
| Q1 2024 | 26 |
| Q2 2024 | 24 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 10 | 10 |
| Q1 2023 | 10 | 7 |
| Q2 2023 | 8 | 11 |
| Q3 2023 | 7 | 12 |
| Q4 2023 | 8 | 12 |
| Q1 2024 | 11 | 12 |
| Q2 2024 | 6 | 10 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $90.8k | $28.6k | 0.32 |
| Q4 2023 | $68.7k | $141.2k | 2.06 |
| Q1 2024 | $12.7k | $80.0k | 6.28 |
| Q2 2024 | $17.1k | $62.5k | 3.67 |
Biggest buyers
| VANGUARD GROUP INC | Added | +221.4k |
| SIMPLEX TRADING, LLC | Added | +1.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +972 |
| BlackRock Inc. | Added | +389 |
| ROYAL BANK OF CANADA | Added | +69 |
| GOLDMAN SACHS GROUP INC | Added | +3 |
Biggest sellers
| MORGAN STANLEY | Reduced | -79.0k |
| ESSEX INVESTMENT MANAGEMENT CO LLC | Sold out | -77.2k |
| CITADEL ADVISORS LLC | Reduced | -2.6k |
| NORTHERN TRUST CORP | Reduced | -2.2k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -2.1k |
| UBS Group AG | Reduced | -728 |
| BANK OF AMERICA CORP /DE/ | Reduced | -553 |
| Mesirow Financial Investment Management, Inc. | Reduced | -380 |
| STIFEL FINANCIAL CORP | Reduced | -250 |
| WELLS FARGO & COMPANY/MN | Sold out | -47 |
Biggest calls
| CITADEL ADVISORS LLC | Added | $17.1k3.3k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CITADEL ADVISORS LLC | Reduced | $31.5k6.1k shares |
| SIMPLEX TRADING, LLC | Reduced | $31.0k6.0k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 1 | $50.0k | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 1 | $190.0k | 0 | — | — |
| Q4 2023 | 1 | $155.8k | 0 | — | — |
| Q1 2024 | 1 | $96.0k | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| BATTERY MANAGEMENT CORP. 3.29% of their portfolio | 2.4m $12.5m | Unchanged |
| NEA Management Company, LLC 0.67% of their portfolio | 1.7m $8.9m | Unchanged |
| TOCQUEVILLE ASSET MANAGEMENT L.P. 0.06% of their portfolio | 684.6k $3.5m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 307.0k $1.6m | Added +221.4k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 122.6k $633.8k | Reduced -2.1k |
| BlackRock Inc. 0.00% of their portfolio | 116.1k $600.1k | Added +389 |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 69.3k $358.3k | Added +3 |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 63.1k $326.2k | Added +972 |
| MORGAN STANLEY 0.00% of their portfolio | 43.1k $222.8k | Reduced -79.0k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 40.5k $209.2k | Reduced -2.2k |
| HighTower Advisors, LLC 0.00% of their portfolio | 34.3k $178.0k | Unchanged |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 30.7k $157.0k | Unchanged |
| Bank of New York Mellon Corp 0.00% of their portfolio | 26.7k $138.3k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 26.6k $137.3k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 25.3k $130.7k | Reduced -553 |
| Cambridge Investment Research Advisors, Inc. 0.00% of their portfolio | 12.3k $63.0k | Unchanged |
| Mesirow Financial Investment Management, Inc. 0.00% of their portfolio | 12.0k $62.0k | Reduced -380 |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 10.9k $56.6k | Reduced -250 |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 10.2k $52.8k | Reduced -2.6k |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 3.0k $15.0k | Added +1.4k |
| UBS Group AG 0.00% of their portfolio | 379 $2.0k | Reduced -728 |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 133 $1.0k | Added +69 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 22 $114 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |